• Rotavirus-Induced Nrf2 Downregulation Impairs Redox Defense

  2026-04-22

  This study demonstrates that progressive rotavirus infection leads to a pronounced and sustained downregulation of the redox-sensitive transcription factor Nrf2 and its downstream antioxidant genes, independent of canonical Nrf2 turnover pathways. These findings clarify mechanisms by which rotavirus manipulates host cell stress responses, with implications for targeted antiviral and inflammation research.

• NMDA (N-Methyl-D-aspartic acid): Precision in Excitotoxicity

  2026-04-22

  NMDA (N-Methyl-D-aspartic acid) enables reproducible modeling of excitotoxicity, oxidative stress, and neurodegeneration. Its use in glaucoma and RGC ferroptosis models exemplifies its versatility and reliability for advanced neuroscience workflows.

• PEDV Relies on IMPDH-Dependent Nucleotide Biosynthesis for R

  2026-04-21

  This study demonstrates that porcine epidemic diarrhea virus (PEDV) exploits host IMPDH-dependent guanine nucleotide biosynthesis to facilitate its replication. Both genetic and pharmacological inhibition of IMPDH, including with Merimepodib (VX-497), robustly impairs PEDV replication, identifying IMPDH as a promising host-directed antiviral target with translational research implications.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Technical Workflow

  2026-04-21

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody is designed for sensitive and specific detection of rabbit primary antibodies in applications such as Western blot, ELISA, and immunohistochemistry. Use this reagent only for research, not diagnostic purposes, and follow defined storage and protocol parameters to ensure reproducibility and signal clarity.

• Optimizing Excitotoxicity Research with NMDA (N-Methyl-D-asp

  2026-04-20

  This article addresses key laboratory challenges in excitotoxicity and neurodegenerative disease modeling using NMDA (N-Methyl-D-aspartic acid), focusing on SKU B1624 from APExBIO. Through scenario-driven Q&A, it demonstrates how this reagent ensures reproducibility, sensitivity, and protocol compatibility for cell viability, oxidative stress, and calcium influx assays.

• Bleomycin Sulfate: Technical Guidance for DNA Damage & Fibro

  2026-04-20

  Bleomycin Sulfate provides a reproducible, quantifiable approach to inducing DNA strand breaks and modeling pulmonary fibrosis in both in vitro and in vivo research. It is best suited for workflows requiring precise DNA damage, cell cycle disruption, or fibrosis simulation, but is not appropriate for experiments needing ethanol solubility or long-term solution stability.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-04-19

  Schwartz's dissertation introduces improved in vitro methods to differentiate between cancer drug effects on cell proliferation and cell death, addressing critical gaps in oncology drug screening. These advances enable more precise assessment of anti-angiogenic therapies and targeted inhibitors, guiding translational research and preclinical evaluation.

• N1-Methyl-Pseudouridine-5'-Triphosphate in RNA Therapeutics

  2026-04-18

  N1-Methyl-Pseudouridine-5'-Triphosphate empowers researchers to engineer longer-lasting, highly translatable RNAs for advanced mRNA therapeutics. Its role in stabilizing RNA and minimizing immune activation streamlines workflows for in vitro transcription and real-world applications like mRNA vaccine and immunotherapy development.

• Sorafenib (BAY-43-9006): Advanced Applications in Cancer Bio

  2026-04-17

  Sorafenib (BAY-43-9006) stands out as a multikinase inhibitor powering next-generation cancer biology research, from dissecting antiangiogenic mechanisms to targeting ATRX-deficient gliomas. This article delivers actionable protocols, troubleshooting insights, and direct translation of cutting-edge findings into experimental success.

• Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Technica

  2026-04-16

  The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) addresses protein degradation during extraction by providing robust, MS-compatible inhibition of endogenous proteases. This reagent is recommended for workflows where preserving protein integrity, especially for mass spectrometry, is critical. It should not be used in applications where AEBSF-mediated serine protease inhibition or chelation of metalloproteinases is required without supplementing with EDTA.

• RNA Purity as the Linchpin for Translational NAFLD Research

  2026-04-15

  This article explores how rigorous RNA purification, enabled by the APExBIO RNA Clean and Concentrator Kit, underpins translational breakthroughs in NAFLD and mitophagy research. We connect mechanistic insights from PINK1/Park2 studies to strategic workflow guidance, benchmarking purification technologies and providing protocol parameters for reproducibility. The discussion escalates beyond standard product descriptions by bridging biological rationale, experimental validation, and translational impact.

• MK-1775 (Wee1 kinase inhibitor): Applied Workflows & Pitfall

  2026-04-14

  MK-1775, a potent Wee1 kinase inhibitor, enables precise abrogation of the G2 DNA damage checkpoint, expanding the toolkit for sensitizing p53-deficient tumor cells in preclinical research. This article delivers actionable workflow guidance, troubleshooting strategies, and evidence-based protocol enhancements drawn from advanced in vitro and in vivo studies.

• Grazoprevir Hydrate: Direct-Acting HCV NS3/4A Protease Inhib

  2026-04-13

  Grazoprevir hydrate (MK-5172 hydrate) is a direct-acting antiviral that targets the hepatitis C virus NS3/4A protease, effectively inhibiting viral replication. It has demonstrated high efficacy against HCV genotypes 1, 4, and 6, including in patients with chronic kidney disease and HIV/HCV coinfection. Clinical studies report sustained virologic response rates between 80% and 99%.

• Translational Strategies with YM-155: Rethinking Survivin In

  2026-04-13

  Explore the mechanistic power and translational value of YM-155 hydrochloride, a potent, highly selective survivin inhibitor. This article guides cancer researchers through the molecule’s rationale, validation, and workflow integration—bridging advanced in vitro methodologies with clinical ambitions, while elevating the discussion beyond typical product guides.

• NFE2L1–UPS Activation by DDI2 Protects Cells from Ferroptosi

  2026-04-12

  This study uncovers how activation of the NFE2L1–ubiquitin-proteasome system (UPS) by the protease DDI2 is central to cellular protection from ferroptosis, an iron-dependent form of regulated cell death. The findings clarify the mechanistic feedback between protein homeostasis and ferroptosis, with implications for cancer and neurodegeneration research.

14662 records 1/978 page Next 12345 下5页 Last page